Vimta Labs Limited (VIMTALABS) Share Price

NSE · Healthcare · Diagnostics & Research · ISIN INE579C01029

₹635.65-16.60 (-2.55%)

Key metrics

Market Cap
₹2,899 Cr
P/E Ratio
36.38
EPS
17.83
Book Value
102.28
P/B Ratio
6.34
ROE
16.97%
ROCE
23.18%
Debt / Equity
0.01
Net Margin
19.03%
Revenue Growth
18.4%
Profit Growth
15.1%
Dividend Yield
0.31%
52W High
₹902.65
52W Low
₹376.05
Market Cap Band
small cap
Face Value
2

Ratios computed from the annual results period ending 2026-03-31.

About Vimta Labs Limited

Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; and a testing laboratory for water, alcoholic, and non-alcoholic beverages. In addition, the company offers environmental regulatory services, such as impact assessments and post project monitoring, to various industries, including power, infrastructure, cement, oil and gas, and mining, etc.; and EMI/EMC testing for electronic and electrical products/components. It provides solutions to agriculture, biologics and biosimilars, home and personal care, medical device, specialty chemicals, food, electrical and electronics, nutraceuticals, water and beverages, pharmaceuticals, crop care, environment, health and safety, and packaging industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India.

Headquarters
Hyderabad, India
Employees
1,384
Promoter Holding
65.68%

The full Vimta Labs Limited analysis

Create a free account to open the complete VIMTALABS deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.

  • 10-year financialsIncome statement, balance sheet and cash flow, year by year.
  • Valuation & fair valueFair-value estimates, quality scores and a value grade.
  • Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
  • Shareholding historyPromoter, FII, DII and public holdings across every quarter.
  • Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
  • Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.